Sangamo Therapeutics
SGMO
SGMO
128 hedge funds and large institutions have $62.9M invested in Sangamo Therapeutics in 2024 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2.65% more ownership
Funds ownership: 26.86% → 29.51% (+2.7%)
44% less call options, than puts
Call options by funds: $1.87M | Put options by funds: $3.35M
Holders
128
Holding in Top 10
–
Calls
$1.87M
Puts
$3.35M
Top Buyers
| 1 | +$4.44M | |
| 2 | +$2.32M | |
| 3 | +$1.9M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.74M |
| 5 |
BlackRock
New York
|
+$1.6M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$2.06M | |
| 3 | -$1.8M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$744K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$418K |